Novonix (NVX) Short term Debt (2020 - 2025)

Novonix (NVX) has reported Short term Debt for 6 consecutive years, with $62.1 million the latest figure, recorded in Q4 2025.

• Quarterly Short term Debt rose 96.0% year-over-year to $62.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62.1 million (up 96.0% YoY) and the FY2025 annual result came in at $62.1 million, up 96.0% from the prior year.
• Short term Debt improved to $62.1 million in Q4 2025 per NVX's latest filing, from $31.7 million in the prior quarter.
• Over the last five years, Short term Debt for NVX reached as high as $62.1 million in Q4 2025 and fell as low as $195666.6 in Q2 2021.
• A 5-year average of $22.2 million and a median of $28.6 million in 2023 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2021 — Short term Debt rose 3.49% — and 2024, when it soared 2420.95%.
• Year by year, Short term Debt stood at $195666.6 in 2021, then jumped by 432.05% to $1.0 million in 2022, then soared by 2642.86% to $28.6 million in 2023, then rose by 10.91% to $31.7 million in 2024, then soared by 96.0% to $62.1 million in 2025.
• According to Business Quant data, Short term Debt over the past three periods registered $62.1 million, $31.7 million, and $30.9 million for Q4 2025, Q4 2024, and Q2 2024 respectively.